Edition:
India

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

19.20USD
24 Apr 2018
Change (% chg)

$-0.25 (-1.29%)
Prev Close
$19.45
Open
$19.57
Day's High
$19.71
Day's Low
$19.03
Volume
32,282
Avg. Vol
94,405
52-wk High
$25.50
52-wk Low
$14.80

Chart for

About

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeuti... (more)

Overall

No Ratios Available.

Financials

BRIEF-Denali Therapeutics Reports Qtrly Net Loss Per Share $0.74

* DENALI THERAPEUTICS ANNOUNCES FIRST-IN-HUMAN DOSING OF ITS RIPK1 INHIBITOR CLINICAL PROGRAM AND THE APPOINTMENT OF PETER KLEIN TO BOARD OF DIRECTORS; REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

19 Mar 2018

BRIEF-Temasek Holdings Dissolves Share Stake In Marin Software, Takes Share Stake In Denali Therapeutics

* TEMASEK HOLDINGS (PRIVATE) LTD DISSOLVES SHARE STAKE IN MARIN SOFTWARE INC - SEC FILING

14 Feb 2018

BRIEF-Denali Therapeutics, Lonza Pharma & Biotech Announce Exclusive Partnership To Develop And Produce Biologic Medicines

* DENALI THERAPEUTICS AND LONZA PHARMA & BIOTECH ANNOUNCE EXCLUSIVE PARTNERSHIP TO DEVELOP AND PRODUCE BIOLOGIC MEDICINES

08 Feb 2018

BRIEF-Takeda And Denali Therapeutics Collaborate To Develop Therapies For Neurodegenerative Diseases

* TAKEDA AND DENALI THERAPEUTICS COLLABORATE TO DEVELOP AND COMMERCIALIZE THERAPIES FOR NEURODEGENERATIVE DISEASES

05 Jan 2018

BRIEF-Denali Therapeutics Says Initial Public Offering Of 13.9 Mln Common Shares Priced At $18 per Share

* DENALI THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

08 Dec 2017

BRIEF-Denali Therapeutics Now Sees IPO Of 13.9 Million Shares Priced Between $17-$19 Per Share

* DENALI THERAPEUTICS INC SEES IPO OF 13.9 MILLION SHARES OF ITS COMMON STOCK PRICED BETWEEN $17.00 AND $19.00 PER SHARE - SEC FILING

07 Dec 2017

Earnings vs. Estimates